Aurinia Pharmaceuticals Market Sentiment

Aurinia Pharmaceuticals Inc

AUPHNASDAQ

$16.90

0.160.96%

Últ. Act.: Oct 21, 5:44 PM

$17.02

0.281.67%

Aurinia Pharmaceuticals Market Sentiment - Benzinga

Market sentiment signals for Aurinia Pharmaceuticals (AUPH): analyst consensus, short interest, options flow and insider activity.

Analyst Consensus▲ Buy

Short Interest▲ 6.6% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

7 analysts

Options Flow (P/C)

—

Avg Consensus PT

$16

-6.8%

Highest Price Target

$21

+23.4%

Jefferies

Lowest Price Target

$10

-41.2%

Cantor Fitzgerald

Short Interest

6.6%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 21, 2026	TD Cowen	Stacy Ku—	+5.8%	$17 → $18	Maintained	Buy
Aug 7, 2026	RBC Capital	Douglas Miehm—	-6.0%	$15 → $16	Maintained	Sector Perform
Dec 3, 2025	Leerink Partners	Joseph Schwartz—	-6.0%	$15 → $16	Downgrade	Outperform→Market Perform
Nov 7, 2025	Jefferies	Maury Raycroft—	+23.4%	$10 → $21	Upgrade	Hold→Buy
Nov 5, 2025	RBC Capital	Douglas Miehm—	-11.9%	$9 → $15	Downgrade	Outperform→Sector Perform
Aug 1, 2025	RBC Capital	Douglas Miehm—	-47.1%	$8 → $9	Maintained	Outperform
Jul 30, 2025	HC Wainwright & Co.	Arthur He—	-0.1%	$17	Assumes	Buy
Sep 16, 2024	Cantor Fitzgerald	Olivia Brayer—	-41.2%	$10 → $10	Maintained	Overweight
Sep 9, 2024	Cantor Fitzgerald	Olivia Brayer—	-41.2%	$10 → $10	Maintained	Overweight
Sep 6, 2024	HC Wainwright & Co.	Ed Arce—	-23.6%	$13 → $13	Maintained	Buy
Mar 1, 2024	HC Wainwright & Co.	Ed Arce—	-23.6%	$13 → $13	Maintained	Buy
Feb 23, 2024	Cantor Fitzgerald	Olivia Brayer—	-41.2%	$12 → $10	Maintained	Overweight
Feb 22, 2024	HC Wainwright & Co.	Ed Arce—	-23.6%	$15 → $13	Maintained	Buy
Feb 16, 2024	RBC Capital	Douglas Miehm—	-53.0%	$13 → $8	Maintained	Outperform